- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01355666
Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting
Evaluate the Efficacy of a Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Additional objectives of this research study are:
- To evaluate healing of pressure ulcers already present or pressure ulcers that develop during the study.
- To evaluate the effectiveness of DermaTherapy® bedding and alternative diapers to reduce the potential for bacterial contamination associated with patients' bed linens, underpads, gowns and pajamas, and thereby help reduce the incidence of facility-acquired infections.
Study nurses will assess the skin of the subjects once or twice a week for the presence of pressure ulcers and measure the size of the pressure ulcers if they are present. Study nurses will also obtain bacterial culture swabs of the bedding weekly for the first eight weeks of the study from five participants in each group.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jack I Twersky, MD
- Phone Number: 7750 919-286-0411
- Email: jack.twersky@ya.gov
Study Contact Backup
- Name: Kenneth E Schmader, MD
- Phone Number: 6769 919-286-0411
- Email: kenneth.schmader@va.gov
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Recruiting
- Durham VA Medical Center
-
Contact:
- Kenneth E Schmader, MD
- Phone Number: 6769 919-286-0411
- Email: kenneth.schmader@va.gov
-
Contact:
- Jack I Twersky, MD
- Phone Number: 7750 919-286-0411
- Email: jack.twersky@va.gov
-
Principal Investigator:
- Jack I Twersky, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Residents admitted for long term care.
- Residents admitted for Hospice Care with an expected length of stay greater than one week.
- Residents with an expected length of stay equal to or greater than 90 days.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: DermaTherapy® Linen group
The DermaTherapy® Linen group uses bed sheets and underpads made with DermaTherapy® fabric.
|
DermaTherapy® Linen is a 100% synthetic silk-like fabric technology designed to provide a cleaner, drier and smoother surface between the skin and support systems for a healthy micro-climate. Subjects in the DermaTherapy® Linen Group are compared to subjects receiving usual care - bed linen made of cotton-blend fabrics.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevention and reduction in the incidence of pressure ulcers
Time Frame: Weekly assessments for 1 year
|
The primary purpose of this research study is to evaluate if DermaTherapy® bedding will significantly reduce pressure ulcer incidence by decreasing maceration, friction, and shearing among residents of Nursing Homes.
|
Weekly assessments for 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of bacterial contamination
Time Frame: Weekly for 8 weeks
|
To evaluate the effectiveness of DermaTherapy® bedding to reduce the potential for bacterial contamination associated with patients' bed linens and thereby help reduce the incidence of facility-acquired infections.
|
Weekly for 8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DermaTherapy
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcers
-
KLOX Technologies Inc.CompletedPressure Ulcers Stage II | Pressure Ulcers Stage IIICanada
-
EmoledRecruitingPressure Ulcer | Pressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure SoreItaly
-
ULURU Inc.United States Department of DefenseRecruitingPressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
Signorini Medicale S.r.l.Opera CRO, a TIGERMED Group CompanyNot yet recruitingBurn Wound | Pressure Ulcers Stage II | Pressure Ulcers Stage IIIRomania
-
Charite University, Berlin, GermanyCompleted
-
Central Arkansas Veterans Healthcare SystemAbbottTerminatedPressure UlcersUnited States
-
Leaf Healthcare, Inc.Centauri Medical, Inc.Completed
-
Hill-RomCompletedPressure UlcersUnited States
-
Bruin Biometrics, LLCCompleted
Clinical Trials on DermaTherapy® Linen and underpads.
-
Precision Fabrics Group, Inc.US Department of Veterans AffairsCompletedPressure UlcersUnited States
-
University of PennsylvaniaCenters for Disease Control and PreventionCompletedCritically IllUnited States
-
Eastern Virginia Medical SchoolCupron Inc.CompletedHospital Acquired InfectionUnited States
-
Universidad del DesarrolloCompletedHealthcare Associated InfectionChile
-
Dong-A ST Co., Ltd.CompletedFunctional DyspepsiaKorea, Republic of
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussis | Diphtheria | PolioUnited States
-
Chung-Ang University Hosptial, Chung-Ang University...UnknownFunctional DyspepsiaKorea, Republic of
-
University of BaghdadCompletedEdentulous Alveolar RidgeIraq
-
Revance Therapeutics, Inc.Active, not recruiting
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussisUnited States